Fig. 2.
Relative total dose intensity (%) for a anthracyclines and b taxanes, separately for BRCA1/2-associated and sporadic breast cancer patients
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.